Position: Professor
School/Academic Group: School of Pharmaceutical Sciences
Email: znyylcsy@126.com
Professional Memberships and/or Notable Appointments:
Hubei Association for Clinical Evaluation of Drugs and Medical Devices, President (2017 - Present)
Chinese Pharmacological Society, Committee on Clinical Trials of Drugs, Vice Chairperson (2018 - Present)
Chinese Society for Medical Ethics, Ethics Development Committee for Biomedical Research Innovation, Vice Chairperson (2020 - Present)
Hainan International Medical Innovation Consortium Foundation, Specialty Committee on Real-World Studies of Drugs and Medical Devices, Vice Chairperson, Secretary-General (2021 - Present)
Research Interests:
Clinical Evaluation of Drugs and Medical Devices；Translation of Medical Scientific and Technological Achievements
Publications：
1.Shipo Wu, Jianying Huang#, Zhe Zhang, Jianyuan Wu, Jinlong Zhang, Hanning Hu, Tao Zhu, Jun Zhang, Lin Luo, Pengfei Fan, Busen Wang, Chang Chen, Yi Chen, Xiaohong Song, Yudong Wang, Weixue Si, Tianjian Sun, Xinghuan Wang, Lihua Hou, Wei Chen, Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial,The Lancet Infectious Diseases, 2021,21（12）：1654-1664.
2.Zeng YN, Wang CY, Lei K, Xiao C, Jiang X, Zhang W, Wu LJ, Huang JY*, Li W, Multifunctional MOF-Based Microneedle Patch With Synergistic Chemo-Photodynamic Antibacterial Effect and Sustained Release of Growth Factor for Chronic Wound Healing, Advanced Healthcare Materials, 2023, 2300250:1-13.
3.Feng Ying,Huang Jianying#,Wu Jianyuan,Xu Yan,Chen Bo,Jiang Lijun,Xiang Hui,Peng Zhiyong,Wang Xinghuan. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study[J]. Cell Proliferation,2020,53(12).
4.Yixin Hu, Jianyuan Wu, Xin Jiang, Guiying Chen, Yang Zhang, Luqin Si, Hongliang Jiang, Jiangeng Huang, Jianying Huang* ,Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects[J]. Journal of pharmaceutical and biomedical analysis, 2022, 217:114826.
5.Chen Chang, Zhang Yi, Huang Jianying#, Yin Ping, Cheng Zhenshun, Wu Jianyuan, Chen Song, Zhang Yongxi, Chen Bo, Lu Mengxin, Luo Yongwen, Ju Lingao, Zhang Jingyi, Wang Xinghuan, Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial. Frontiers in Pharmacology,2021,12:2292.
6.Fu M, Luo L, Feng S, Lin H, Lu Z, Gu F, Fan Y, Wu B, Huang J, Shen K. Effect of SHR0302 on the Pharmacokinetics of CYP3A4, CYP2C8, CYP2C9, and CYP2C19 Probe Substrates in Healthy Volunteers: A Cocktail Analysis. Br J Clin Pharmacol. 2023 Jul 19.
